Amylyx Pharmaceuticals, Inc.
AMLX
$14.05
$0.261.89%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 79.59% | 46.76% | -41.63% | -45.33% | -52.47% |
| Total Receivables | -65.63% | -86.60% | -95.16% | -98.55% | -98.65% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -47.48% | 0.26% | -53.92% | -29.02% | -14.18% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 70.86% | 44.08% | -42.80% | -47.35% | -59.23% |
|
|
|||||
| Total Current Assets | 70.86% | 44.08% | -42.80% | -47.35% | -59.23% |
| Net Property, Plant & Equipment | 100.99% | 66.57% | 47.50% | -63.72% | -57.39% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 136.94% | 81.12% | 21.12% | 20.46% | -96.83% |
| Total Assets | 71.79% | 44.68% | -41.41% | -47.38% | -62.58% |
|
|
|||||
| Total Accounts Payable | 19.73% | 259.05% | -33.52% | -77.58% | -86.68% |
| Total Accrued Expenses | -25.22% | -61.41% | -72.17% | -82.22% | -58.51% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -17.06% | -50.25% | -71.93% | -54.37% | -32.74% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -20.13% | -52.16% | -69.43% | -80.43% | -65.38% |
|
|
|||||
| Total Current Liabilities | -20.13% | -52.16% | -69.43% | -80.43% | -65.38% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 914.69% | 732.61% | 586.14% | -76.34% | -76.62% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -5.14% | -43.60% | -62.29% | -80.37% | -65.64% |
|
|
|||||
| Common Stock & APIC | 36.90% | 37.26% | 12.34% | 12.80% | 4.52% |
| Retained Earnings | -23.86% | -26.23% | -37.79% | -51.65% | -98.95% |
| Treasury Stock & Other | 539.13% | 27.15% | 668.04% | -- | -146.70% |
| Total Common Equity | 85.27% | 69.21% | -35.76% | -37.92% | -61.99% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 85.27% | 69.21% | -35.76% | -37.92% | -61.99% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 85.27% | 69.21% | -35.76% | -37.92% | -61.99% |
|
|
|||||